ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

CMS Dares Critics To Produce ESA Data; House Bill Seeks To Vacate Coverage Decision.

September 28, 2007

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991

In Brief: Former PHS Official Jeffrey Koplan To Head CDC; Caligiuri Wins Freireich Award

July 17, 1998

Women 80 And Older Benefit From Mammography

May 30, 2008

Chemotherapy Patients Can Benefit From Heart Failure Treatment, Study Finds

October 25, 2002